A detailed history of Jfs Wealth Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 7,652 shares of VTRS stock, worth $81,340. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,652
Previous 7,776 1.59%
Holding current value
$81,340
Previous $84,000 8.33%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$11.27 - $13.53 $1,397 - $1,677
-124 Reduced 1.59%
7,652 $91,000
Q4 2023

Feb 07, 2024

SELL
$8.77 - $10.85 $140 - $173
-16 Reduced 0.21%
7,776 $84,000
Q3 2023

Nov 02, 2023

BUY
$9.59 - $11.35 $1,371 - $1,623
143 Added 1.87%
7,792 $76,000
Q2 2023

Aug 07, 2023

SELL
$9.02 - $10.29 $432 - $493
-48 Reduced 0.62%
7,649 $76,000
Q1 2023

Apr 19, 2023

BUY
$9.2 - $12.26 $312 - $416
34 Added 0.44%
7,697 $74,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $191 - $254
-22 Reduced 0.29%
7,663 $85,000
Q3 2022

Oct 21, 2022

SELL
$8.48 - $11.13 $1,085 - $1,424
-128 Reduced 1.64%
7,685 $65,000
Q2 2022

Aug 02, 2022

BUY
$9.95 - $12.27 $1,592 - $1,963
160 Added 2.09%
7,813 $82,000
Q1 2022

May 02, 2022

BUY
$9.81 - $15.4 $1,402 - $2,202
143 Added 1.9%
7,653 $84,000
Q4 2021

Feb 03, 2022

SELL
$12.09 - $14.68 $930 - $1,130
-77 Reduced 1.01%
7,510 $102,000
Q3 2021

Nov 09, 2021

SELL
$13.25 - $15.13 $1,073 - $1,225
-81 Reduced 1.06%
7,587 $103,000
Q2 2021

Aug 04, 2021

SELL
$12.97 - $16.15 $635 - $791
-49 Reduced 0.63%
7,668 $110,000
Q1 2021

Apr 28, 2021

SELL
$13.59 - $18.54 $54,767 - $74,716
-4,030 Reduced 34.31%
7,717 $108,000
Q4 2020

Feb 01, 2021

BUY
$14.3 - $18.74 $167,982 - $220,138
11,747 New
11,747 $220,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Jfs Wealth Advisors, LLC Portfolio

Follow Jfs Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.